Potential mechanism for myeloma drug’s variable toxicity
Apr. 30, 2014—A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
E-records shed light on drug response
Mar. 31, 2014—Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.
Mapping brain circuitry
Mar. 28, 2014—Vanderbilt investigators have used two types of neuroimaging to establish a “map” of connections for a brain region important in anxiety and addiction.
Flu boosts pneumococcal colonization
Mar. 27, 2014—Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.
A pain in the … genes
Jan. 10, 2014—Vanderbilt researchers have discovered that variation in the gene encoding the potassium channel GIRK1 plays a role in modulating human pain perception.
Rhythm response tied to gene variant
Jun. 21, 2013—A genetic variant that increases risk for atrial fibrillation also impacts the response to a common therapy for the heart rhythm disorder.
Symposium highlights VU’s clinical, translational research
Nov. 29, 2012—Nearly $5 million in internal pilot grants to jumpstart research projects. A tripling in the number of clinical and translational research publications. Novel research tools that have been snapped up by scientists around the world.
Vanderbilt’s CTSA lands $46 million renewal
Jul. 12, 2012—Vanderbilt University’s largest single government research grant, its Clinical and Translational Science Award (CTSA), has been renewed for another five years for $46 million.
Matchmaker for clinical studies
Feb. 8, 2012—ResearchMatch.org is a web-based registry that is connecting participants and researchers for clinical studies.
VUMC awarded $20M to coordinate science consortium
Jun. 14, 2011—Consortium will advance biomedical research nationwide.
Stents relieve post-infection problem
May. 5, 2011—Placing stents in blood vessels can provide long-term relief from rare complications of a fungal lung infection.